AKR1C3 and posterior cortical atrophy: The overexpression of AKR1C3 have been correlated with PCa progression and aggressiveness [45,46] and recent findings describe the activation of AKR1C3 as a mechanism of resistance to Enzalutamide and Abiraterone [47,48].